Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue

Mylène A. Carrascal, Catarina Talina, Paula Borralho, A. Gonçalo Mineiro, Ana Raquel Henriques, Cláudia Pen, Manuela Martins, Sofia Braga, Robert Sackstein, Paula A. Videira

Research output: Contribution to journalArticle

3 Citations (Scopus)
20 Downloads (Pure)

Abstract

Background: The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield new biomarkers for patient stratification and aid in identifying novel therapeutic targets. The determinants of selectin ligands consist of sialylated tetrasaccharides, the sialyl Lewis X and A (sLeX and sLeA), displayed on protein or lipid scaffolds. Standardized procedures for immunohistochemistry make use of the antibodies against sLeX and/or sLeA. However, antibody binding does not define E-selectin binding activity. Methods: In this study, we developed an immunohistochemical staining technique, using E-selectin-human Ig Fc chimera (E-Ig) to characterize the expression and localization of E-selectin binding sites on paraffin-embedded sections of different cancer tissue. Results: E-Ig successfully stained cancer cells with high specificity. The E-Ig staining show high reactivity scores in colon and lung adenocarcinoma and moderate reactivity in triple negative breast cancer. Compared with reactivity of antibody against sLeX/A, the E-Ig staining presented higher specificity to cancer tissue with better defined borders and less background. Conclusions: The E-Ig staining technique allows the qualitative and semi-quantitative analysis of E-selectin binding activity on cancer cells. The development of accurate techniques for detection of selectin ligands may contribute to better diagnostic and better understanding of the molecular basis of tumor progression and metastasis.

Original languageEnglish
Article number495
JournalBMC Cancer
Volume18
Issue number1
DOIs
Publication statusPublished - 2 May 2018

Fingerprint

E-Selectin
Paraffin
Staining and Labeling
Ligands
Neoplasms
Selectins
Antibodies
Triple Negative Breast Neoplasms
Neoplasm Metastasis
Tumor Microenvironment
Cell Adhesion
Colon
Endothelial Cells
Biomarkers
Immunohistochemistry
Binding Sites
Lipids

Keywords

  • Cancer
  • E-selectin ligands
  • Sialyl-Lewis a
  • Sialyl-Lewis X

Cite this

Carrascal, Mylène A. ; Talina, Catarina ; Borralho, Paula ; Mineiro, A. Gonçalo ; Henriques, Ana Raquel ; Pen, Cláudia ; Martins, Manuela ; Braga, Sofia ; Sackstein, Robert ; Videira, Paula A. / Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue. In: BMC Cancer. 2018 ; Vol. 18, No. 1.
@article{ccacccc938a94ee4a58eaafefbb41b13,
title = "Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue",
abstract = "Background: The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield new biomarkers for patient stratification and aid in identifying novel therapeutic targets. The determinants of selectin ligands consist of sialylated tetrasaccharides, the sialyl Lewis X and A (sLeX and sLeA), displayed on protein or lipid scaffolds. Standardized procedures for immunohistochemistry make use of the antibodies against sLeX and/or sLeA. However, antibody binding does not define E-selectin binding activity. Methods: In this study, we developed an immunohistochemical staining technique, using E-selectin-human Ig Fc chimera (E-Ig) to characterize the expression and localization of E-selectin binding sites on paraffin-embedded sections of different cancer tissue. Results: E-Ig successfully stained cancer cells with high specificity. The E-Ig staining show high reactivity scores in colon and lung adenocarcinoma and moderate reactivity in triple negative breast cancer. Compared with reactivity of antibody against sLeX/A, the E-Ig staining presented higher specificity to cancer tissue with better defined borders and less background. Conclusions: The E-Ig staining technique allows the qualitative and semi-quantitative analysis of E-selectin binding activity on cancer cells. The development of accurate techniques for detection of selectin ligands may contribute to better diagnostic and better understanding of the molecular basis of tumor progression and metastasis.",
keywords = "Cancer, E-selectin ligands, Sialyl-Lewis a, Sialyl-Lewis X",
author = "Carrascal, {Myl{\`e}ne A.} and Catarina Talina and Paula Borralho and Mineiro, {A. Gon{\cc}alo} and Henriques, {Ana Raquel} and Cl{\'a}udia Pen and Manuela Martins and Sofia Braga and Robert Sackstein and Videira, {Paula A.}",
note = "info:eu-repo/grantAgreement/EC/H2020/676421/EU# SFRH/BD/100970/2014 This work was supported by the LPCC/Pfizer2011 and Portuguese Foundation for Science and Technology (FCT) - SFRH/BD/100970/2014 (MAC) and Premio Santander/ Totta - UNL, Bluepharma/UC (PAV), by the National Institutes of Health, in particular, the National Heart Lung Blood Institute (NHLBI) Program of Excellence in Glycosciences (PEG) grant PO1 HL107146 (RS) and by the GlycoCan Marie Curie Actions (grant agreement number 676421). All the funding bodies supported the acquisition for all the required material for experiments and analysis, besides a fellowship for MAC.",
year = "2018",
month = "5",
day = "2",
doi = "10.1186/s12885-018-4410-x",
language = "English",
volume = "18",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BIOMED CENTRAL LTD",
number = "1",

}

Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue. / Carrascal, Mylène A.; Talina, Catarina; Borralho, Paula; Mineiro, A. Gonçalo; Henriques, Ana Raquel; Pen, Cláudia; Martins, Manuela; Braga, Sofia; Sackstein, Robert; Videira, Paula A.

In: BMC Cancer, Vol. 18, No. 1, 495, 02.05.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue

AU - Carrascal, Mylène A.

AU - Talina, Catarina

AU - Borralho, Paula

AU - Mineiro, A. Gonçalo

AU - Henriques, Ana Raquel

AU - Pen, Cláudia

AU - Martins, Manuela

AU - Braga, Sofia

AU - Sackstein, Robert

AU - Videira, Paula A.

N1 - info:eu-repo/grantAgreement/EC/H2020/676421/EU# SFRH/BD/100970/2014 This work was supported by the LPCC/Pfizer2011 and Portuguese Foundation for Science and Technology (FCT) - SFRH/BD/100970/2014 (MAC) and Premio Santander/ Totta - UNL, Bluepharma/UC (PAV), by the National Institutes of Health, in particular, the National Heart Lung Blood Institute (NHLBI) Program of Excellence in Glycosciences (PEG) grant PO1 HL107146 (RS) and by the GlycoCan Marie Curie Actions (grant agreement number 676421). All the funding bodies supported the acquisition for all the required material for experiments and analysis, besides a fellowship for MAC.

PY - 2018/5/2

Y1 - 2018/5/2

N2 - Background: The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield new biomarkers for patient stratification and aid in identifying novel therapeutic targets. The determinants of selectin ligands consist of sialylated tetrasaccharides, the sialyl Lewis X and A (sLeX and sLeA), displayed on protein or lipid scaffolds. Standardized procedures for immunohistochemistry make use of the antibodies against sLeX and/or sLeA. However, antibody binding does not define E-selectin binding activity. Methods: In this study, we developed an immunohistochemical staining technique, using E-selectin-human Ig Fc chimera (E-Ig) to characterize the expression and localization of E-selectin binding sites on paraffin-embedded sections of different cancer tissue. Results: E-Ig successfully stained cancer cells with high specificity. The E-Ig staining show high reactivity scores in colon and lung adenocarcinoma and moderate reactivity in triple negative breast cancer. Compared with reactivity of antibody against sLeX/A, the E-Ig staining presented higher specificity to cancer tissue with better defined borders and less background. Conclusions: The E-Ig staining technique allows the qualitative and semi-quantitative analysis of E-selectin binding activity on cancer cells. The development of accurate techniques for detection of selectin ligands may contribute to better diagnostic and better understanding of the molecular basis of tumor progression and metastasis.

AB - Background: The E-selectin ligands expressed by cancer cells mediate adhesion of circulating cancer cells to endothelial cells, as well as within tissue microenvironments important for tumor progression and metastasis. The identification of E-selectin ligands within cancer tissue could yield new biomarkers for patient stratification and aid in identifying novel therapeutic targets. The determinants of selectin ligands consist of sialylated tetrasaccharides, the sialyl Lewis X and A (sLeX and sLeA), displayed on protein or lipid scaffolds. Standardized procedures for immunohistochemistry make use of the antibodies against sLeX and/or sLeA. However, antibody binding does not define E-selectin binding activity. Methods: In this study, we developed an immunohistochemical staining technique, using E-selectin-human Ig Fc chimera (E-Ig) to characterize the expression and localization of E-selectin binding sites on paraffin-embedded sections of different cancer tissue. Results: E-Ig successfully stained cancer cells with high specificity. The E-Ig staining show high reactivity scores in colon and lung adenocarcinoma and moderate reactivity in triple negative breast cancer. Compared with reactivity of antibody against sLeX/A, the E-Ig staining presented higher specificity to cancer tissue with better defined borders and less background. Conclusions: The E-Ig staining technique allows the qualitative and semi-quantitative analysis of E-selectin binding activity on cancer cells. The development of accurate techniques for detection of selectin ligands may contribute to better diagnostic and better understanding of the molecular basis of tumor progression and metastasis.

KW - Cancer

KW - E-selectin ligands

KW - Sialyl-Lewis a

KW - Sialyl-Lewis X

UR - http://www.scopus.com/inward/record.url?scp=85046263550&partnerID=8YFLogxK

U2 - 10.1186/s12885-018-4410-x

DO - 10.1186/s12885-018-4410-x

M3 - Article

VL - 18

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 495

ER -